Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: A systematic review and meta-analysis

Published:2024-01 Issue:1 Volume:71 Page:79-88
ISSN:0019-5707
Container-title:Indian Journal of Tuberculosis
language:en
Short-container-title:Indian Journal of Tuberculosis

Author:

Ahmed Syeda Hoorulain^ORCID,Haider Hoorain,Moeed Abdul,Mahmood Aysal,Shivani Nasir,Shuja Syed Hasan,Hayat Javeria,Jamil Bushra,Fatima Razia

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference58 articles.

1. Tuberculosis. Accessed December 21, 2021. https://www.who.int/news-room/fact-sheets/detail/tuberculosis.

2. Treatment for extreme drug-resistant tuberculosis wins US government approval;Maxmen;Nature,2019

3. Global Health - Newsroom - Tuberculosis. Accessed December 21, 2021. https://www.cdc.gov/globalhealth/newsroom/topics/tb/index.html.

4. Global tuberculosis report 2021. Accessed December 21, 2021. https://www.who.int/publications/i/item/9789240037021.

5. Bedaquiline: a novel antitubercular drug for multidrug-resistant tuberculosis;Nagabushan;J Postgrad Med,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysis;New Microbes and New Infections;2024-08

2. A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug‐Resistant and Extensively Drug‐Resistant Mycobacterium tuberculosis;Journal of Clinical Laboratory Analysis;2024-08

3. Real-life use of delamanid: results from the European post-authorisation safety study;IJTLD OPEN;2024-06-01

4. Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia;The International Journal of Mycobacteriology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3